Stockreport

Pfenex Earns $11 Million Development Milestone under its Development and License Agreement with Jazz Pharmaceuticals

PFENEX INC  (PFNX) 
NASDAQ:AMEX Investor Relations: pfenex.com
PDF SAN DIEGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE American: PFNX) today announced that it has earned an $11 million development milestone under its devel [Read more]